These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 12933676

  • 41. Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism.
    Alberti L, Proverbio MC, Costagliola S, Romoli R, Boldrighini B, Vigone MC, Weber G, Chiumello G, Beck-Peccoz P, Persani L.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2549-55. PubMed ID: 12050212
    [Abstract] [Full Text] [Related]

  • 42. Differential effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone/chorionic gonadotropin receptors.
    Cetani F, Tonacchera M, Vassart G.
    FEBS Lett; 1996 Jan 02; 378(1):27-31. PubMed ID: 8549796
    [Abstract] [Full Text] [Related]

  • 43. Analysis of differentiation-induced expression mechanisms of thyrotropin receptor gene in adipocytes.
    Shimura H, Miyazaki A, Haraguchi K, Endo T, Onaya T.
    Mol Endocrinol; 1998 Oct 02; 12(10):1473-86. PubMed ID: 9773972
    [Abstract] [Full Text] [Related]

  • 44. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism.
    Duprez L, Parma J, Van Sande J, Allgeier A, Leclère J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J.
    Nat Genet; 1994 Jul 02; 7(3):396-401. PubMed ID: 7920658
    [Abstract] [Full Text] [Related]

  • 45. Interaction of human chorionic gonadotropin (hCG) and asialo-hCG with recombinant human thyrotropin receptor.
    Hoermann R, Broecker M, Grossmann M, Mann K, Derwahl M.
    J Clin Endocrinol Metab; 1994 Apr 02; 78(4):933-8. PubMed ID: 8157724
    [Abstract] [Full Text] [Related]

  • 46. Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP.
    Derwahl M, Kuemmel M, Goretzki P, Schatz H, Broecker M.
    Biochem Biophys Res Commun; 1993 Mar 31; 191(3):1131-8. PubMed ID: 8385451
    [Abstract] [Full Text] [Related]

  • 47. The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor.
    Rossi M, Dimida A, Dell'anno MT, Trincavelli ML, Agretti P, Giorgi F, Corsini GU, Pinchera A, Vitti P, Tonacchera M, Maggio R.
    J Pharmacol Exp Ther; 2007 Jan 31; 320(1):465-74. PubMed ID: 17062616
    [Abstract] [Full Text] [Related]

  • 48. Identification of TSH receptor mutations in three families with resistance to TSH.
    Tonacchera M, Di Cosmo C, De Marco G, Agretti P, Banco M, Perri A, Gianetti E, Montanelli L, Vitti P, Pinchera A.
    Clin Endocrinol (Oxf); 2007 Nov 31; 67(5):712-8. PubMed ID: 17697008
    [Abstract] [Full Text] [Related]

  • 49. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
    Hidaka A, Okajima F, Ban T, Kosugi S, Kondo Y, Kohn LD.
    J Clin Endocrinol Metab; 1993 Nov 31; 77(5):1164-9. PubMed ID: 8077307
    [Abstract] [Full Text] [Related]

  • 50. Current standards, variations, and pitfalls for the determination of constitutive TSHR activity in vitro.
    Mueller S, Jaeschke H, Paschke R.
    Methods Enzymol; 2010 Nov 31; 485():421-36. PubMed ID: 21050930
    [Abstract] [Full Text] [Related]

  • 51. Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies.
    Kosugi S, Ban T, Akamizu T, Valente W, Kohn LD.
    J Clin Endocrinol Metab; 1993 Jul 31; 77(1):19-24. PubMed ID: 8100829
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.
    Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G.
    Nature; 1993 Oct 14; 365(6447):649-51. PubMed ID: 8413627
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Role of the cyclic adenosine 3',5'-monophosphate response element in efficient expression of the rat thyrotropin receptor promoter.
    Ikuyama S, Shimura H, Hoeffler JP, Kohn LD.
    Mol Endocrinol; 1992 Oct 14; 6(10):1701-15. PubMed ID: 1333054
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Pituitary-thyroid setpoint and thyrotropin receptor expression in consomic rats.
    Moeller LC, Alonso M, Liao X, Broach V, Dumitrescu A, Van Sande J, Montanelli L, Skjei S, Goodwin C, Grasberger H, Refetoff S, Weiss RE.
    Endocrinology; 2007 Oct 14; 148(10):4727-33. PubMed ID: 17640981
    [Abstract] [Full Text] [Related]

  • 60. Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse.
    Stein SA, Oates EL, Hall CR, Grumbles RM, Fernandez LM, Taylor NA, Puett D, Jin S.
    Mol Endocrinol; 1994 Feb 14; 8(2):129-38. PubMed ID: 8170469
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.